China Grand Pharmaceutical and Healthcare Holdings Ltd - ESG Rating & Company Profile powered by AI
If you are employed by China Grand Pharmaceutical and Healthcare Holdings Ltd and you wish to use your ESG aseessment, please contact us. This page displays a free ESG analysis for China Grand Pharmaceutical and Healthcare Holdings Ltd. This dashboard contains a questions and answers table for China Grand Pharmaceutical and Healthcare Holdings Ltd.
China Grand Pharmaceutical and Healthcare Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | China Grand Pharmaceutical and Healthcare Holdings Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does China Grand Pharmaceutical and Healthcare Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose current and historical energy intensity?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd report the average age of the workforce?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd reference operational or capital allocation in relation to climate change?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose its ethnicity pay gap?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose cybersecurity risks?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd offer flexible work?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose the number of employees in R&D functions?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd conduct supply chain audits?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does China Grand Pharmaceutical and Healthcare Holdings Ltd conduct 360 degree staff reviews?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose the individual responsible for D&I?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose current and / or historical scope 2 emissions?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose water use targets?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd have careers partnerships with academic institutions?
Did China Grand Pharmaceutical and Healthcare Holdings Ltd have a product recall in the last two years?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose incidents of discrimination?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Has China Grand Pharmaceutical and Healthcare Holdings Ltd issued a profit warning in the past 24 months?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose parental leave metrics?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose climate scenario or pathway analysis?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose the pay ratio of women to men?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd support suppliers with sustainability related research and development?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is China Grand Pharmaceutical and Healthcare Holdings Ltd involved in embryonic stem cell research?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose GHG and Air Emissions intensity?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose its waste policy?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd report according to TCFD requirements?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose energy use targets?
Does China Grand Pharmaceutical and Healthcare Holdings Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does China Grand Pharmaceutical and Healthcare Holdings Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for China Grand Pharmaceutical and Healthcare Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency medicines; respiratory, ophthalmic, anti-infection, and ENT medicines; oncology medicines; and rare disease medicines. It also provides medical devices, such as vascular interventional medical devices comprising paclitaxel releasing coronary balloon dilatation catheters and paclitaxel releasing hemodialysis shunt balloon dilatation catheters; and ophthalmology related devices. In addition, the company offers biotechnology and health products, such as Taurine, amino acid products, steroid products, and bio-pesticides and agricultural antibiotics; and specialized pharmaceutical raw materials and other products, including metronidazole, chloramphenicol, epinephrine, dimethyl sulfate, nitromethane, etc. Further, the company offers agrochemicals, fine chemicals, and chemical medicines; ophthalmic gel and eye drops; steroid hormones active pharmaceutical ingredients and related intermediates; bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited and changed its name to Grand Pharmaceutical Group Limited in November 2021. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.